Skip to main content
search

Market Access & Commercial

Sign up

Latest resources

Featured resource

Market access & commercial resources

Leveraging Real-World Evidence (RWE) in Rare Disease Drug Development
Leveraging Real-World Evidence (RWE) in Rare Disease Drug DevelopmentVideo

Leveraging Real-World Evidence (RWE) in Rare Disease Drug Development

The path to regulatory approval and market access for rare disease therapies presents unique challenges. With small patient populations and heterogeneous data, the development…
Pharmacometrics Drug Development Decision Support: Model-Based Meta-Analysis (MBMA)
Pharmacometrics Drug Development Decision Support: Model-Based Meta-Analysis (MBMA)Fact Sheet

Pharmacometrics Drug Development Decision Support: Model-Based Meta-Analysis (MBMA)

Best Practices for International Pharma Content Roll-Out
Best Practices for International Pharma Content Roll-OutBlog

Best Practices for International Pharma Content Roll-Out

January 31, 2025 Pharmaceutical market access, sales, and field teams rely on high-quality, effective content to demonstrate their products’ value…
CMS Cell and Gene Therapy (CGT) Access Model Explained: The Most Significant Drug Pricing Legislation You’ve Never Heard Of
CMS Cell and Gene Therapy (CGT) Access Model Explained: The Most Significant Drug Pricing Legislation You’ve Never Heard OfBlog

CMS Cell and Gene Therapy (CGT) Access Model Explained: The Most Significant Drug Pricing Legislation You’ve Never Heard Of

December 13, 2024 The Centers for Medicare & Medicaid Services (CMS) is piloting a program that would negotiate and administer…

Latest market access & commercialization blogs

Meet our experts at the following events

DIA Europe 2025
DIA Europe 2025Conference

DIA Europe 2025

March 18-20, 2025 - Basel, Switzerland - Booth F2
Lab of the Future USA
Lab of the Future USAConference

Lab of the Future USA

Conference: Lab of the Future USA Date: March 10-11, 2025 Location: Boston, MA Presenters: Nick…

All resources heading

DIA Europe 2025

Conference - Discovery LP, Conference - Early Clinical LP, Conference - Late Clinical LP, Conference - Market Access & Commercial LP, Conference - Regulatory LP, Conference – Resources LP, Conference LP - Latest, Conference

AMCP 2025

Conference LP - Latest, Conference

BioIT World 2025

Conference - Discovery LP, Conference – Resources LP, Conference LP - Latest, Conference

Pharmacometrics Drug Development Decision Support: Model-Based Meta-Analysis (MBMA)

Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Fact Sheet

Best Practices for International Pharma Content Roll-Out

Certara Products, Certara Products - BaseCase, Certara Services, Market Access & Commercial - Blog, Blog

CMS Cell and Gene Therapy (CGT) Access Model Explained: The Most Significant Drug Pricing Legislation You’ve Never Heard Of

Biologics, Cell and Gene Therapy, Certara Services, Evidence and Access, Blog

Top Three Insights from Certainty Europe

pre-update, Blog

Mastering Value Storytelling with Data-Driven Stories

Certara Products, Certara Products - BaseCase, Certara Services, Market Access & Commercial - Blog, pre-update, Value, Value Communication, Blog

Joint Clinical Assessment (JCA) and Joint Scientific Consultation (JSC) Solutions

pre-update, Fact Sheet

4 Ways to Optimize Agency Partnerships Using a Platform-Oriented Approach 

Certara Products, Certara Products - BaseCase, Certara Services, Market Access & Commercial - Blog, pre-update, Value Communication, Blog

JSCPT 2024 – The 45th Japan Society of Clinical Pharmacology and Therapeutics

pre-update, Conference

Adapting Value Stories for Global Healthcare Markets

pre-update, On-Demand Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.